Table 3.
Rheumatoid arthritis | Comparators | |
---|---|---|
Entire analyzed study sample | ||
COPD, cases/n (%) | 68/843 (8.1%) | 459/8,399 (5.5%) |
Asthma, cases/n (%)* | 40/843 (4.7%) | 268/8,399 (3.2%) |
Among never smokers at index date | ||
COPD, cases/n (%) | 9/300 (3.0%) | 85/3,700 (2.3%) |
Asthma, cases/n (%)* | 14/300 (4.7%) | 114/3,700 (3.1%) |
Among never or <10 pack-years at index date | ||
COPD, cases/n (%) | 19/438 (4.3%) | 128/5,115 (2.5%) |
Asthma, cases/n (%)* | 19/438 (4.3%) | 163/5,115 (3.2%) |
Follow-up after index date, person-years** | 15,716 | 157,768 |
Mean follow-up after index date per participant, years (SD)** | 18.6 (9.0) | 18.8 (9.5) |
Women who reported both asthma and COPD during follow-up were classified as COPD for all analyses.
Follow-up is reported for the entire analyzed study sample.
COPD, chronic obstructive pulmonary disease; SD, standard deviation.